Priming of T cells by heat shock protein-peptide complexes as the basis of tumor vaccines

Seminars in Immunology

Volumn 9, Issue 5, 1997, Pages 315-322

  Li, Zihai ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Antigen presentation; Cytotoxic T lymphocyte; Heat shock protein; MHC; Peptide; Tumor vaccine

Indexed keywords

HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TUMOR REJECTION ANTIGEN; TUMOR VACCINE;

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; CANCER IMMUNIZATION; REVIEW; T LYMPHOCYTE; VACCINATION;

EID: 0031252213     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1006/smim.1997.0087     Document Type: Article

References (52)

1. 1. Gross L (1943) Intradermal immunization of C3H mice against a sarcoma that originated in an animal of the same line. Cancer Res 3:323-326
2. 2. Baldwin RW (1955) Immunity to methylchalanthrene-induce tumors in inbred rats following atrophy and regression of the implanter tumors. Br J Cancer 9:652-657
3. 3. Prehn RT, Main JM (1957) Immunity to methylcholanthrene-induced sarcomas. J Natl Cancer Inst 18:769
4. 4. Klein G, Sjogren HO, Klein E, Hellstrom KE (1960) Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary authochthonous host. Cancer Res 20:1561-1572
5. 5. Old LJ, Boyse EA, Clarke DA, Carswell EA (1962) Antigenic properties of chemically induced tumors. Ann NY Acad Sci 101:80-106
6. 6. Boon T, van der Bruggen P (1996) Human tumor antigens recognized by T lymphocytes. J Exp Med 183:725-729
7. 7. Parsell DA, Linquist S (1993) The function of heat shock proteins in stress tolerance: degradation and reactivation of damaged proteins. Annu Rev Genetics 27:437-496
8. 8. Gething MJ, Sambrook J (1992) Protein folding in the cell. Nature 355:33-45
9. 9. Srivastava PK, Maki RG (1991) Stress-induced proteins in immune response to cancer. Curr Top Microbiol Immunol 167:109-123
10. 10. Srivastava PK, Das MR (1984) The serologically unique cell surface antigen of Zajdela ascitis hepatoma is also its tumor-associated transplantation antigen. Int J Cancer 33:417-422
11. 11. Srivastava PK, DeLeo AB, Old LJ (1986) Tumor-rejection antigens of chemically induced sarcomas of imbred mice. Proc Natl Acad Sci USA 83:3407-3411
12. 12. Udono H, Srivastava PK (1994) Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90 and hsp70. J Immunol 152:5398-5403
13. 13. Srivastava PK (1993) Peptide-binding heat shock proteins in the endoplasmic reticulum: role in immune response to cancer and in antigen presentation. Adv Cancer Res 62:153
14. 14. Flynn GC, Chappell TG, Rothman JE (1989) Peptide binding and release by proteins implicated as catalysts of protein assembly. Science 245:385-390
15. 15. Flynn GC, Pohl J, Flocco MT, Rothman JE (1991) Peptide-binding specificity of the molecular chaperone Bip. Nature 353:726-730
16. 16. Fourie AM, Sambrook JF, Gething MJ (1994) Common and divergent peptide binding specificities of hsp70 molecular chaperones. J Biol Chem 268:30470-30481
17. 17. Townsend A, Bodmer H (1989) Antigen recognition by class I-restricted T lymphocytes. Annu Rev Immunol 7:601-624
18. 18. Yewdell JW, Bennick JR (1992) Cell biology of antigen processing and presentation to MHC class I molecule-restricted T lymphocytes. Adv Immunol 52:1-123
19. 19. Udono H, Srivastava PK (1993) Heat shock protein 70-associated peptides elicit specific cancer immunity. J Exp Med 178:1391-1396
20. 20. Nieland TJ, Tan MC, Monne-van MM, Koning F, Kruisbeek AM, van Bleek GM (1996) Isolation of an immunodominant viral peptide that is endogeneously bound to the stress protein gp96/ grp94. Proc Natl Acad Med Sci USA 93:6135-6139
21. 21. Udono H, Levey DL, Srivastava PK (1994) Definition of T cell subsets mediating tumor-specific immunogenicity of cognate heat shock protein gp96. Proc Natl Acad Sci USA 91:307
22. 22. Peng P, Menoret A, Srivastava PK (1997) ADP-affinity purified heat shock protein 70-peptide complexes elicit tumor specific immunity. J Immunol Methods 204:13-21
23. 23. Blachere NE, Udono H, Janetzki S, Li Z, Heike M, Srivastava PK (1993) Heat shock protein vaccines against cancer. J Immunother 14:352
24. 24. Arnold D, Faath S, Rammensee HG, Schild H (1995) Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96. J Exp Med 182:885-889
25. 25. Janetzki S, Blachere NE, Daou M, Srivastava PK (1997) Cognate heat shock protein gp96 preparations from two antigenically distinct UV-induced carcinomas elicit tumor-specific rejection and cytotoxic T lymphocyte response. J Immunother in press
26. 26. Menoret A, Patry Y, Burg C, Pendu JL (1995) Co-segregation of tumor immunogenicity with expression of inducible but not constitutive hsp70 in rat colon carcinomas. J Immunol 155:740-747
27. 27. Li Z, Srivastava PK (1994) A critical contemplation on the role of heat shock proteins in transfer of antigenic peptides during antigen presentation. Behring Inst Mitt 94:37-47
28. 28. Srivastava PK, Udono H, Blachere NE, Li Z (1994) Heat shock proteins transfer peptides during antigen processing and CTL-priming. Immunogenetics 39:93-98
29. 29. Zhu X, Zhao X, Burkholder WF, Gragerov A, Ogata CM, Gottesman ME, Hendrickson (1996) Structural analysis of substrate binding by the molecular chaperone DnaK Science 272:1606-1614
30. 30. Nadler SG, Tepper MA, Schacter B, Mazzucco CE (1992) Interaction of the immunosuppressant deoxyspergualin with a member of the hsp70 family of heat shock proteins. Science 258:484-486
31. 31. Li Z, Srivastava PK (1993) Tumor rejection antigen gp96/ grp94 is an ATPase: implications for protein folding and antigen presentation. EMBO J 12:314
32. 32. Darrow TL, Slingluff CL Jr, Siegler HF (1989) The role of HLA class I antigens in recognition of melanoma cell by tumor-specific cytotoxic T lymphocytes: evidence for shared tumor antigens. J Immunol 142:3329
33. 33. Kawakami Y, Zakut R, Topalian SL, Stotter H, Rosenberg SA (1992) Shared human melanoma antigens. Recognition by tumor-infiltrating lymphocytes in HLA-A2.1-transfected melanomas. J Immunol 148:638-643
34. 34. Falo LD Jr, Kovacsovics-Bankowski M, Thompson K, Rock KL (1995) Targeting antigen into the phagocytic pathway in vivo induces protective tumor immunity. Nature Medicine 1:649-653
35. 35. Suto R, Srivastava PK (1995) A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 269:1585-1588
36. 36. Blachere NE, Li Z, Chandawarkar RY, Suto R, Jaikaria NS, Basu S, Udono H, Srivastava PK (1997) Heat shock protein -peptide complexes, reconstituted in vitro, elicit pep tide specific cytotoxic T lymphocyte response and tumor immunity.. J Exp Med (in press)
37. 37. Tiwari RK (1996) Protective immunity to tumor-derived gp96 in the Dunning G rat prostate cancer model, in Cancer Vaccine 1996, Abstract M40. Cancer Research Institute, New York
38. 38. Tamura Y, Peng P, Liu K, Daou M, Srivastava PK (1997) Immunotherapy of cancers with autologous cancer-derived heat shock protein preparations. Science (in press)
39. 39. Srivastava PK (1997) Purification of heat shock protein-peptide complexes for use in vaccination against cancers and intracellular pathogens. Immunol Methods Manual, pp 739-748. Academic Press, London
40. 40. Heike M, Blachere NE, Srivastava PK (1994) Protective cellular immunity against a spontaneous mammary carcinoma from ras transgenic mice. Immunobiology 190:411-423
41. 41. Barrios C, Georgopoulos C, Lambert PH, Del Giudice G (1994) Heat shock proteins as carrier molecules: in vivo helper effect mediated by Escherichia coli GroEL and DnaK proteins requires cross-linking with antigen. Clin Exp Immunol 98:229-233
42. 42. Janetzki S, Rosenhauer V, Palla D, Srivastava PK, Lochs H (1996) Immunization of cancer patients with autologous cancer-derived heat shock protein-peptide complexes - a pilot study, in Cancer Vaccine 1996, Abstract T68
43. 43. Levey DL, Srivastava PK (1996) Alterations in T cells of cancer-bearers: whence specificity?. Immunol Today 17:365-368
44. 44. DeNagel DC, Pierce SK (1992) A case for chaperones in antigen processing. Immunol Today 13:86-89
45. 45. Lakey EK, Margoliash E, Pierce SK (1987) Identification of a peptide binding protein that plays a role in antigen presentation. Proc Natl Acad Sci USA 84:1659-1663
46. 46. Srivastava PK, Hieke M (1991) Tumor-specific immunogenicity of stress-induced proteins: convergence of two evolutionary pathways of antigen presentation?. Semin Immunol 3:57-64
47. 47. Srivastava PK (1994) Heat shock proteins in immune response to cancer: fourth paradigm. Experientia 50:1054-1060
48. 48. Blachere NE, Srivastava PK (1995) Heat shock protein-based cancer vaccines and related thoughts on immunogenicity of human tumors. Semin Cancer Biol 6:349-355
49. 49. Matzinger P (1994) Tolerance, danger, and the extended family. Annu Rev Immunol 12:991-1045
50. 50. Fuchs EJ, Matzinger P (1996) Is cancer dangerous to the immune system?. Semin Immunol 8:271-280
51. 51. Altmeyer A, Maki RG, Feldweg AN, Heike M, Protopopov VP, Masur SK, Srivastava PK (1996) Tumor-specific cell surface expression of the KDEL containing, endoplasmic reticular heat shock protein gp96. Int J Cancer 69:340-349
52. 52. Booth C, Koch GL (1989) Pertubation of cellular calcium induces secretion of luminal ER proteins. Cell 59:729-737